Skip to main content
placeholder image

Phase I study of a novel S1P inhibitor, NOX66, in combination with radiotherapy in patients with metastatic castration-resistant prostate cancer.

Journal Article


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2020

Citation


  • de Souza, P. L., Capp, A. L., Chikhladze, N., Mezvrishvili, Z., Messina, M., & Mautner, G. (2020). Phase I study of a novel S1P inhibitor, NOX66, in combination with radiotherapy in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology, 38(15_suppl), 5533. doi:10.1200/jco.2020.38.15_suppl.5533

Web Of Science Accession Number


Start Page


  • 5533

End Page


  • 5533

Volume


  • 38

Issue


  • 15_suppl

Place Of Publication


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2020

Citation


  • de Souza, P. L., Capp, A. L., Chikhladze, N., Mezvrishvili, Z., Messina, M., & Mautner, G. (2020). Phase I study of a novel S1P inhibitor, NOX66, in combination with radiotherapy in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology, 38(15_suppl), 5533. doi:10.1200/jco.2020.38.15_suppl.5533

Web Of Science Accession Number


Start Page


  • 5533

End Page


  • 5533

Volume


  • 38

Issue


  • 15_suppl

Place Of Publication